TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pro Ox Bio AB
Closing information (x1000 EUR)
Closing information | 2024/08 | 2023/08 | 2022/08 |
Turnover |
199
|
206 | |
Financial expenses |
5
|
4 | |
Earnings before taxes |
96
|
95 | |
EBITDA |
104
|
103 | |
Total assets |
303
|
230 | |
Current assets |
104
|
72 | |
Current liabilities |
27
|
14 | |
Equity capital |
26
|
27 | |
- share capital |
4
|
5 | |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Solvency |
8.6%
|
11.7% | |
Turnover per employee |
199
|
206 | |
Profit as a percentage of turnover |
48.2%
|
46.1% | |
Return on assets (ROA) |
33.3%
|
43.0% | |
Current ratio |
385.2%
|
514.3% | |
Return on equity (ROE) |
369.2%
|
351.9% | |
Change turnover |
13
|
45 | |
Change turnover % |
-23%
|
7%
|
28% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.